Neopterin in Acute Pancreatitis
Authors:
- 1 January 1996
- journal article
- research article
- Published by Taylor & Francis in Scandinavian Journal of Gastroenterology
- Vol. 31 (10) , 1032-1036
Abstract
Background: Activation of the cellular immune system may play a role in the pathogenesis of acute pancreatitis (AP); it has recently been proposed that excessive leukocyte stimulation may lead to the most severe forms of AP. The aim of this study was to investigate serum neopterin, a useful in vivo marker of macrophage activation, in mild and severe AP and its relationship with other markers of leukocyte activation, such as interleukin-6 (IL-6) and tumor necrosis factor (TNF). Methods: Serum levels of neopterin (mmol/ml), IL-6 (pg/ml), and TNF (pg/ml) were measured on the 1st and 7th day of hospitalization in 17 patients with severe AP and 24 with mild AP. Severe AP was defined in accordance with the Atlanta criteria: all patients have necrosis at contrast-enhanced computerized tomography scan. Results: Day 1: Neopterin and IL-6 levels were significantly higher in the severe than in the mild AP and normal controls; mild AP values were also significantly higher than in normal controls. The best neopterin cutoff level we obtained (30 mmol/ml) reached a specificity of 76% and a sensitivity of 46% in distinguishing severe from mild AP. Day 7: Neopterin was significantly higher in severe AP than in mild AP and in normal controls; no difference was seen between mild AP values and normal controls; neopterin serum levels were significantly higher on day 7 than on day 1 in severe AP but not in mild AP; in both groups of patients IL-6 was significantly higher on day 1 than on day 7. Using a neopterin cutoff level of 40 mmol/ml, we found a specificity and sensitivity value of 92% in differentiating severe from mild AP. With regard to TNF values, no difference was seen on days 1 and 7 in the two groups of patients in comparison with normal controls. Neopterin serum values did not correlate with IL-6 and TNF on either day. Conclusions: These results confirm the activation of the cellular immune system in AP. Initially enhanced NEOP and IL-6 serum levels reflect the severity of the disease; neopterin may be considered a reliable prognostic indicator also at a distance from AP onset because its levels increase during the 1st week of AP in patients with severe forms only.Keywords
This publication has 22 references indexed in Scilit:
- Neopterin and soluble tumor necrosis factor receptor type I in alcohol-induced cirrhosisHepatology, 1995
- Piasma Neopterin/C-Reactive Protein Ratio as an Adjunct to the Assessment of Infection and Cancer CachexiaImmunological Investigations, 1995
- Monitoring of serum proteinase-antiproteinase balance and systemic inflammatory response in prognostic evaluation of acute pancreatitisDigestive Diseases and Sciences, 1993
- Role of interleukin-6 in mediating the acute phase protein response and potential as an early means of severity assessment in acute pancreatitis.Gut, 1993
- Endotoxaemia and serum tumour necrosis factor as prognostic markers in severe acute pancreatitis.Gut, 1992
- lnterleukin‐8 and neutrophil activation in acute pancreatitisEuropean Journal of Clinical Investigation, 1992
- Neopterin in clinical practiceClinica Chimica Acta, 1991
- Granulocyte elastase in assessment of severity of acute pancreatitisDigestive Diseases and Sciences, 1990
- C-reactive protein, antiproteases and complement factors as objective markers of severity in acute pancreatitisBritish Journal of Surgery, 1989
- Fatal pancreatitis, a consequence of excessive leukocyte stimulation?International journal of pancreatology, 1988